PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,655 stories, page 313 of 645

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07738627: Effects of IMT on Cardiopulmonary Endurance and Functional Mobility in KOA

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07644559: A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07606274: A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07588191: Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07536308: A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07535359: Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer

Study type: EXPANDED_ACCESS. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07482696: Electromyographic Biofeedback Therapy in Patients With Dyssynergic Defecation

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07459660: An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07448844: Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07376018: Ketogenic Diet and Neuromodulation in Treatment Resistant Depression

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07216703: A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07178158: Enhancing Addiction Treatment Through Psychoeducation

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07173829: A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07048600: Brief Trial of ACT-i for Adults With Chronic Insomnia

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06983691: Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06890598: Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06854042: A Study of Oral E1018 in Healthy Adult Participants

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06707844: TF and MFR on Calf Muscles in Patients With Pes Planus

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06686615: A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06670014: Evaluate the Efficacy and Safety of the Digital Therapeutics Repeech for the Post-Stroke Dysarthria.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06305598: Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06247085: A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05697874: International Rare Brain Tumor Registry

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05668013: A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05400746: A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05357612: Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05243862: Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05237986: Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05058677: Aerosolized Endotracheal Lidocaine to Avoid Intracranial Pressure Spikes in Patients With Severe Traumatic Brain Injury

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03805919: Men at High Genetic Risk for Prostate Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03573024: Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03135886: Project I Test: Implementing HIV Testing in Opioid Treatment Programs

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02759744: Fusion Guided Focal Laser Ablation of Prostate Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02639299: Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02455557: SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01728571: LungVITamin D and OmegA-3 Trial (lungVITAL)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01425892: The Pathogenesis and Natural History of Sjogren's Disease

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01352962: Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00392353: Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00341679: Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00092235: Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00001971: Evaluation of Patients With Liver Disease

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Talent and Market Access Should Drive Biotech Location Decisions

BioPharm InternationalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Safe to Try: The Simplest Way to Accelerate Cures and Bring Down Prescription Drug Prices

Americans for ProsperityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Slotkin, Ricketts Introduce Bipartisan Legislation to Keep Biotech Industry in America, Not China

U.S. Senate (.gov)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Puma Biotech (PBYI) Q2 Earnings and Revenues Top Estimates

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical Q2 Earnings Call Highlights

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates

Investing News NetworkOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Radiopharmaceutical May Benefit Patients with Metastatic Prostate Cancer Sooner

news.weill.cornell.eduOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is Retatrutide Safe?

Yahoo CreatorsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Return of the rubber stamp? First mRNA flu vaccine has far higher injury rate than standard jabs

Just The NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Puma Biotech earnings beat by $0.16, revenue topped estimates

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Relay Therapeutics Q2 2026 earnings: Clinical spending rises with cash runway into 2029

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical (BMRN) Surpasses Q2 Earnings and Revenue Estimates

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical Inc. reports results for the quarter ended June 30 - Earnings Summary

TradingViewOriginal source
🇺🇸Researchorbimed.comTier 2 · Direct publisher

Braveheart Bio Announces Pricing of Upsized Initial Public Offering

OrbiMedOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech (MBRX) stake capped at 4.99% under Intracoastal warrants

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

After two rejections and mass layoffs, Replimune melanoma drug wins FDA approval

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Goldman Sachs reiterates Neutral on Annexon stock after GBS data

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA on Peptides: A New Landscape for Compounders

Latham & Watkins LLPOriginal source